Solid Biosciences (SLDB) Other Working Capital Changes (2017 - 2026)

Solid Biosciences has reported Other Working Capital Changes for 4 years, with the latest figure at -$496000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 19.23% year-over-year to -$496000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 15.26% YoY) and the FY2025 annual result came in at -$1.8 million, down 6.56% from the prior year.
• Other Working Capital Changes was little changed at -$496000.0 in Q1 2026 per SLDB's latest filing, from -$495000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $7.6 million in Q4 2025 and troughed at -$6.2 million in Q2 2022.
• A 5-year average of $324437.5 and a median of -$273000.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes rose 12.66% in 2024, then retreated 19.57% in 2025.
• Over 4 years, Other Working Capital Changes stood at -$474000.0 in 2023, then grew by 12.66% to -$414000.0 in 2024, then decreased by 19.57% to -$495000.0 in 2025, then dropped by 0.2% to -$496000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$496000.0, -$495000.0, and -$443000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.